212 related articles for article (PubMed ID: 28159857)
21. Androgens in prostate cancer: A tale that never ends.
Hou Z; Huang S; Li Z
Cancer Lett; 2021 Sep; 516():1-12. PubMed ID: 34052327
[TBL] [Abstract][Full Text] [Related]
22. The Role of Sialyl-Tn in Cancer.
Munkley J
Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
[TBL] [Abstract][Full Text] [Related]
23. N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor.
Itkonen HM; Mills IG
PLoS One; 2013; 8(5):e65016. PubMed ID: 23724116
[TBL] [Abstract][Full Text] [Related]
24. Androgen Signaling in the Tumor Microenvironment.
Özdemir BC
Adv Exp Med Biol; 2021; 1270():169-183. PubMed ID: 33123999
[TBL] [Abstract][Full Text] [Related]
25. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
Montgomery RB; Mostaghel EA; Vessella R; Hess DL; Kalhorn TF; Higano CS; True LD; Nelson PS
Cancer Res; 2008 Jun; 68(11):4447-54. PubMed ID: 18519708
[TBL] [Abstract][Full Text] [Related]
26. Molecular regulation of androgen action in prostate cancer.
Dehm SM; Tindall DJ
J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
[TBL] [Abstract][Full Text] [Related]
27. Androgen Control in Prostate Cancer.
Pelekanou V; Castanas E
J Cell Biochem; 2016 Oct; 117(10):2224-34. PubMed ID: 27104784
[TBL] [Abstract][Full Text] [Related]
28. Androgens and androgen receptor signaling in prostate tumorigenesis.
Zhou Y; Bolton EC; Jones JO
J Mol Endocrinol; 2015 Feb; 54(1):R15-29. PubMed ID: 25351819
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor: structure, role in prostate cancer and drug discovery.
Tan MH; Li J; Xu HE; Melcher K; Yong EL
Acta Pharmacol Sin; 2015 Jan; 36(1):3-23. PubMed ID: 24909511
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.
Ottaviani S; Brooke GN; O'Hanlon-Brown C; Waxman J; Ali S; Buluwela L
J Mol Endocrinol; 2013 Dec; 51(3):301-12. PubMed ID: 23997240
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
32. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells.
Miyake H; Hara I; Arakawa S; Kamidono S
J Cell Biochem; 2000 Apr; 77(3):396-408. PubMed ID: 10760948
[TBL] [Abstract][Full Text] [Related]
33. Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.
Zhang L; Zhao Z; Xu S; Tandon M; LaValle CR; Deng F; Wang QJ
Oncotarget; 2017 Feb; 8(8):12800-12811. PubMed ID: 28077787
[TBL] [Abstract][Full Text] [Related]
34. Androgen action and metabolism in prostate cancer.
Green SM; Mostaghel EA; Nelson PS
Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214
[TBL] [Abstract][Full Text] [Related]
35. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.
Frigo DE; Howe MK; Wittmann BM; Brunner AM; Cushman I; Wang Q; Brown M; Means AR; McDonnell DP
Cancer Res; 2011 Jan; 71(2):528-37. PubMed ID: 21098087
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
37. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
38. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
39. Altered glycosylation in prostate cancer.
Drake RR; Jones EE; Powers TW; Nyalwidhe JO
Adv Cancer Res; 2015; 126():345-82. PubMed ID: 25727153
[TBL] [Abstract][Full Text] [Related]
40. An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.
Wang H; Sun D; Ji P; Mohler J; Zhu L
J Cell Sci; 2008 Aug; 121(Pt 15):2578-87. PubMed ID: 18628304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
